Darin Lippoldt, Chief Legal Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 10,000 shares at $169.56 ($1.7M) on 2026-06-26, disclosed to the SEC on 2026-06-30.
Scheduled sale ($1.7M) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $169.56 | 200 | $34K | 2.0% |
| 2 | $170.03 | 8,110 | $1.4M | 81.0% |
| 3 | $170.81 | 1,690 | $289K | 17.0% |
| Total | $170.15 avg | 10,000 | $1.7M | 100% |
| Filing → |
| NBIX | SELL | 2025-02-14 | $510K | — | Filing → |
| NBIX | SELL | 2025-02-12 | $215K | — | Filing → |
| NBIX | SELL | 2025-02-04 | $382K | — | Filing → |